The complaint filed alleges that, between February 5, 2020, and August 14 ... they failed to disclose that GSK possessed unpublished data – the Tanner Report – that did exactly that; (3 ...

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against GSK plc. ("GSK" or the "Company") . IF ...

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

The treatment landscape for HER2-positive NSCLC is rapidly evolving as research continues to reveal the genetic drivers of these tumors. Emerging therapies like Pyrotinib (Jiangsu HengRui Medicine), ...

London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing ...

London stocks had nudged higher by midday on Friday as investors digested a raft of UK data releases, while Standard ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

The success of an ongoing pilot programme offering RSV vaccination to newborn infants provides hope in tackling the ...

Chinese tech stocks rose on the back of strong earnings seen by Alibaba, whose shares are up 14 per cent in overnight trading ...

BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESRE ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...